New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group
Diane Thiboutot(Penn State Milton S. Hershey Medical Center), John E. Wolf(Georgetown University), Brigitte Dréno(Nantes Université), A.Y. Finlay(Cardiff University), María Isabel Herane(University of Chile), Jaime Piquero Martín(Hospital Vargas), Harald Gollnick(University Hospital Magdeburg), Márcia Ramos‐e‐Silva(Universidade Federal do Rio de Janeiro), Vicente Torres Lozada(Hospital Juárez de México), Alison Layton(University of York), Sewon Kang(Johns Hopkins University), Alan R. Shalita(State University of New York), Montserrat Pérez, Yoshiki Miyachi(Kyoto University), Chee Leok Goh(Cornell University), Diane Berson(Cornell University), Raj Kubba, A Kaminsky(Universidad de Buenos Aires), Neil H. Shear(Sunnybrook Health Science Centre), Jo Ann See, Vincenzo Bettoli(University of Ferrara)
Cited by 835
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
|Clinical and Experimental Dermatology|1994|5.5k
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
|New England Journal of Medicine|2014|2k
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k
The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis..
|British Journal of Dermatology|1994|1.3k